| Literature DB >> 30496315 |
Ilona Lukas1, Alexandra Kohl-Schwartz1,2, Kirsten Geraedts1, Martina Rauchfuss3, Monika M Wölfler4, Felix Häberlin5, Stephanie von Orelli6, Markus Eberhard7, Bruno Imthurn1, Patrick Imesch8, Brigitte Leeners1.
Abstract
Endometriosis affects various aspects of women's lives. We searched for predictors for patient satisfaction with medical support (PSwMS) in women with endometriosis. The study was designed as a multi-centre retrospective cohort study. We approached women with histologically confirmed endometriosis from 2010 until 2016, comparing women satisfied to women dissatisfied with medical support. We analysed data on characteristics of endometriosis, PSwMS and the influence of disease characteristics on PSwMS. Information on satisfaction with medical support was collected through a standardized questionnaire. After exclusion of 73 women because of inchoately filled in questionnaires, data from 498 women was evaluated. Altogether, it was observed that 54.6% (n = 272) of the study participants were satisfied with medical support and 45.4% (n = 226) were not. Feeling adequately informed by the time of diagnosis (p < 0.001), taking women's mental troubles seriously (p < 0.001) and supporting women in handling their pain (p < 0.001) were significantly associated with satisfaction. We found adequate information to be the most distinctive indicator for PSwMS. Further, acknowledging psychological distress and supporting women in handling their symptoms rather than to alleviate them, positively affect PSwMS. To achieve PSwMS, healthcare providers have to give adequate information on endometriosis and its management.Entities:
Mesh:
Year: 2018 PMID: 30496315 PMCID: PMC6264517 DOI: 10.1371/journal.pone.0208023
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sociodemographic characteristics and potential confounders.
| 37.3 ± 7.1 | 38.5 ± 7 | 0.071 | |
| WrHPO (n = 432) | 37.1 ± 7.2 | 37.3 ± 6.8 | 0.757 |
| WfSHG (n = 65) | 40.6 ± 5.3 | 42.9 ± 5.7 | 0.146 |
| <0.001 | |||
| Swiss | 132 (48.5) | 69 (30.5) | |
| German | 110 (40.4) | 131 (58) | |
| Austrian | 5 (1.8) | 3 (1.3) | |
| Others | 25 (9.2) | 20 (8.8) | |
| 0.059 | |||
| Swiss | 132 (48.5) | 69 (30.5) | |
| German | 92 (33.8) | 85 (37.6) | |
| Austrian | 5 (1.8) | 3 (1.3) | |
| Others | 25 (9.2) | 19 (8.4) | |
| 0.533 | |||
| Swiss | 0 (0) | 0 (0) | |
| German | 18 (6.6) | 46 (20.4) | |
| Austria | 0 (0) | 0 (0) | |
| Others | 0 (0) | 1 (0.4) | |
| 0.17 | |||
| Married/ long-term relationship | 232 (85.3) | 180 (79.6) | |
| Single | 40 (14.7) | 43 (19) | |
| 0.181 | |||
| Married/ long-term relationship | 216 (79.4) | 141 (62.4) | |
| Single | 38 (14) | 35 (15.5) | |
| 0.555 | |||
| Married/ long-term relationship | 16 (5.9) | 39 (17.3) | |
| Single | 2 (0.7) | 8 (3.5) | |
| 0.022 | |||
| 0-12 months | 83 (30.5) | 49 (21.7) | |
| 13-60 months | 106 (39) | 89 (39.4) | |
| 61-120 months | 43 (15.8) | 44 (19.5) | |
| >121 months | 18 (6.6) | 33 (14.6) | |
| (n = 465) | 24.5 | 39 | <0.001 |
| (n = 400) | 22.5 | 34.5 | 0.026 |
| (n = 65) | 50.5 | 83 | 0.093 |
| 0.772 | |||
| Stage I | 41 (15.1) | 41 (18.1) | |
| Stage II | 62 (22.8) | 41 (18.1) | |
| Stage III | 74 (27.2) | 69 (30.5) | |
| Stage IV | 95 (34.9) | 75 (33.2) | |
| 0.443 | |||
| Stage I | 41 (15.1) | 38 (16.8) | |
| Stage II | 59 (21.7) | 31 (13.7) | |
| Stage III | 68 (25) | 57 (25.2) | |
| Stage IV | 86 (11.6) | 53 (23.5) | |
| 0.538 | |||
| Stage I | 0 (0) | 3 (1.3) | |
| Stage II | 3 (1.1) | 10 (4.4) | |
| Stage III | 6 (2.2) | 12 (5.3) | |
| Stage IV | 9 (3.3) | 22 (9.7) | |
| Total study group (n = 467) | 1 | 2 | <0.001 |
| WrHPO (n = 402) | 1 | 2 | 0.008 |
| WfSHG (n = 65) | 2 | 2 | 0.171 |
| Total study group | 115 (42.3) | 104 (46) | 0.403 |
| WrHPO | 105 (38.6) | 79 (35) | 0.819 |
| WfSHG | 10 (3.6) | 25 (11.1) | 0.228 |
| Total study group | 115 (42.3) | 138 (61.1) | <0.001 |
| WrHPO | 101 (37.1) | 100 (44.2) | 0.001 |
| WfSHG | 14 (5.1) | 38 (16.8) | 0.231 |
a: p-value based on an independent t-test analysis
b: p-value based on a Pearson Chi-Square test analysis
c: p-value based on a Mann Whitney test analysis
Satisfaction with medical support in relation to addressing key endometriosis-associated symptoms (n = 498).
| the time of diagnosis | 36.9 | 20.1 | 16.7 | <0.001 |
| a later date | 28.1 | 25.7 | 26.5 | 0.005 |
| the time of diagnosis | 35.5 | 16.5 | 14.5 | <0.001 |
| a later date | 26 | 19.8 | 23.3 | 0.003 |
| the time of diagnosis | 1.4 | 3.6 | 2.2 | 0.999 |
| a later date | 2.2 | 5.8 | 3.2 | 0.884 |
| the time of diagnosis | 23.3 | 5.6 | 8.4 | <0.001 |
| a later date | 20.3 | 13.3 | 15.3 | <0.001 |
| the time of diagnosis | 22.3 | 4.8 | 7.8 | <0.001 |
| a later date | 18.5 | 10.8 | 14.7 | <0.001 |
| the time of diagnosis | 1 | 0.8 | 0.6 | 0.122 |
| a later date | 1.8 | 2.4 | 0.6 | 0.094 |
| the time of diagnosis | 6.2 | 1.2 | 16.7 | <0.001 |
| a later date | 8.0 | 6.2 | 17.9 | <0.001 |
| the time of diagnosis | 6 | 1 | 16.5 | <0.001 |
| a later date | 6.4 | 4.2 | 17.6 | <0.001 |
| the time of diagnosis | 0.2 | 0.2 | 0.2 | 0.643 |
| a later date | 1.6 | 2 | 0.2 | 0.116 |
a: Percentages were calculated in relation to the total number of participants (n = 498)
b: p-value based on a Pearson Chi-Square test analysis
Assessment of provided information and education.
Comparing medians.
| Total study group | 6 | 3 | <0.001 |
| WrHPO | 7 | 3 | <0.001 |
| WfSHG | 4 | 2 | 0.01 |
| used a well comprehensible language to explain the condition | |||
| Total study group | 6 | 3 | <0.001 |
| WrHPO | 6 | 4 | <0.001 |
| WfSHG | 5 | 3 | 0.001 |
| provided enough time to answer my questions | |||
| Total study group | 7 | 3 | <0.001 |
| WrHPO | 7 | 4 | <0.001 |
| WfSHG | 5 | 3 | <0.001 |
| Total study group | 6 | 2 | <0.001 |
| WrHPO | 6 | 2 | <0.001 |
| WfSHG | 4 | 2 | 0.008 |
| Total study group | 6 | 2 | <0.001 |
| WrHPO | 6 | 2 | <0.001 |
| WfSHG | 4 | 2 | <0.001 |
| Total study group | 6 | 2 | <0.001 |
| WrHPO | 6 | 2 | <0.001 |
| WfSHG | 4 | 2 | 0.001 |
| Total study group | 7 | 3 | <0.001 |
| WrHPO | 7 | 4 | <0.001 |
| WfSHG | 6 | 3 | <0.001 |
| Total study group | 6 | 3 | <0.001 |
| WrHPO | 6 | 3 | <0.001 |
| WfSHG | 6 | 3 | <0.001 |
| Total study group | 6 | 3 | <0.001 |
| WrHPO | 6 | 3 | <0.001 |
| WfSHG | 4 | 3 | 0.048 |
| Total study group | 6 | 2 | <0.001 |
| WrHPO | 6 | 3 | <0.001 |
| WfSHG | 4.5 | 2 | <0.001 |
| Total study group | 3 | 1 | <0.001 |
| WrHPO | 3 | 1 | <0.001 |
| WfSHG | 2 | 1 | 0.008 |
| Total study group | 4 | 1 | <0.001 |
| WrHPO | 4 | 1 | <0.001 |
| WfSHG | 2 | 1 | 0.033 |
| Total study group | 5 | 3 | <0.001 |
| WrHPO | 5 | 3 | <0.001 |
| WfSHG | 4.5 | 2.5 | 0.001 |
| Total study group | 6 | 3 | <0.001 |
| WrHPO | 6 | 3 | <0.001 |
| WfSHG | 5.5 | 3 | <0.001 |
| Total study group | 6 | 3 | <0.001 |
| WrHPO | 6 | 2 | <0.001 |
| WfSHG | 5.5 | 3 | 0.002 |
| Total study group | 4 | 2 | <0.001 |
| WrHPO | 4 | 2 | <0.001 |
| WfSHG | 3.5 | 1 | 0.001 |
| Total study group | 4 | 2 | <0.001 |
| WrHPO | 4 | 2 | <0.001 |
| WfSHG | 3.5 | 1 | 0.011 |
| Total study group | 6 | 2 | <0.001 |
| WrHPO | 6 | 2 | <0.001 |
| WfSHG | 5 | 2 | <0.001 |
| Total study group | 2 | 1 | <0.001 |
| WrHPO | 2 | 1 | <0.001 |
| WfSHG | 2 | 1 | 0.031 |
| Total study group | 3 | 1 | <0.001 |
| WrHPO | 3 | 1 | <0.001 |
| WfSHG | 2 | 1 | <0.001 |
The scale was from 1 to 7, women rated 7 if they agreed and 1 if they disagreed.
a: P-value is based on a Mann Whitney test analysis
Suggestions to improve medical support (n = 265).
| 1) Better education about endometriosis through doctors, gynaecologists or brochures, including information about cause and healing | 52 |
| 2) Create a treatment plan adjusted to suit personal preferences and requirements including alternative treatment, treatment for symptoms and psychological issues | 42 |
| 3) Taking women and their pain seriously | 35 |
| 4) Doctors should be better qualified or take further training | 28 |
| 5) Doctors should suggest information centres, endometriosis associations, lectures or self-help groups | 28 |
| 6) Doctors should take more time to explain endometriosis and talk to the patient about it | 28 |
| 7) More information about treatment possibilities and process, e.g. pain treatment, operations and treatment after operations | 21 |
| 8) There should be more information about endometriosis in public and schools | 17 |
| 9) Timely diagnosis, early detection and evaluation | 17 |
| 10) More sensitivity from doctors regarding infertility | 8 |
| 11) Better communication among doctors | 7 |
| 12) Positive thinking without raising false hopes | 7 |
| 13) Pay more attention to symptoms and individual issues | 5 |
| 14) More information about sexuality | 4 |
Fig 1Sources for information gathering.
Multiple answers were possible. P-value1: satisfied vs. dissatisfied total study group; p-value2: satisfied vs. dissatisfied WrHPO; p-value3: satisfied vs. dissatisfied WfSHG. Internet: n = 362; Communication with doctor: n = 322; Books/Magazines: n = 230; Communication with other affected women: n = 142; Internet exchange with other affected women: n = 80; Others: n = 62.
Fig 2a-f: Sources experienced most helpful to gather information. a) in satisfied WrHPO (n); b) in dissatisfied WrHPO (n); c) in satisfied WfSHG (n); d) in dissatisfied WfSHG (n); e) in WrHPO; f) in WfSHG (n); A: Communication with doctors (n = 198); B: Internet (n = 153); C: Books/Magazines (n = 33); D: Exchange with affected women (n = 38); E: Online exchange with affected women (n = 7); F: Others (n = 14).
Regression analysis.
| Predictors for PSwMS | p-value | Exp(B) | 95% C.I. for Exp(B) | |
|---|---|---|---|---|
| Lower | Upper | |||
| Felt adequately informed by the time of diagnosis | ||||
| Took my mental troubles seriously | ||||
| Supported me in handling my pain | ||||
Hosmer and Lemeshow Test Chi-square=2.804; df=7, p-value=0.902